Table of Contents
ISRN Obstetrics and Gynecology
Volume 2012 (2012), Article ID 512732, 5 pages
http://dx.doi.org/10.5402/2012/512732
Clinical Study

A High Dose Intravenous Immunoglobulin Therapy for Women with Four or More Recurrent Spontaneous Abortions

1Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan
2Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan
3KKR Sapporo Medical Center, Sapporo, Japan
4Mommy’s Clinic Chitose, Chitose, Japan

Received 15 March 2012; Accepted 7 August 2012

Academic Editors: K. Chan, J. M. Goldberg, and R. G. Lea

Copyright © 2012 Hideto Yamada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Laird, E. M. Tuckerman, B. A. Cork, S. Linjawi, A. I. F. Blakemore, and T. C. Li, “A review of immune cells and molecules in women with recurrent miscarriage,” Human Reproduction Update, vol. 9, no. 2, pp. 163–174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. O. B. Christiansen, R. Steffensen, H. S. Nielsen, and K. Varming, “Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications,” Gynecologic and Obstetric Investigation, vol. 66, no. 4, pp. 257–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. K. Pandey, R. Rani, and S. Agrawal, “An update in recurrent spontaneous abortion,” Archives of Gynecology and Obstetrics, vol. 272, no. 2, pp. 95–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. T. C. Li, M. Makris, M. Tomsu, E. Tuckerman, and S. Laird, “Recurrent miscarriage: aetiology, management and prognosis,” Human Reproduction Update, vol. 8, no. 5, pp. 463–481, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. D. A. Clark, “Immunological factors in pregnancy wastage: fact or fiction,” American Journal of Reproductive Immunology, vol. 59, no. 4, pp. 277–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Shetty and K. Ghosh, “Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss—a review of literature of various therapeutic protocols,” American Journal of Reproductive Immunology, vol. 62, no. 1, pp. 9–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Toth, U. Jeschke, N. Rogenhofer et al., “Recurrent miscarriage: current concepts in diagnosis and treatment,” Journal of Reproductive Immunology, vol. 85, no. 1, pp. 25–32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. E. E. Winger and J. L. Reed, “Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion,” American Journal of Reproductive Immunology, vol. 60, no. 1, pp. 8–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. E. E. Winger, J. L. Reed, S. Ashoush, S. Ahuja, T. El-Toukhy, and M. Taranissi, “Treatment with Adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF,” American Journal of Reproductive Immunology, vol. 61, no. 2, pp. 113–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Scarpellini and M. Sbracia, “Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial,” Human Reproduction, vol. 24, no. 11, pp. 2703–2708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Yamada, T. Kishida, N. Kobayashi, E. H. Kato, N. Hoshi, and S. Fujimoto, “Massive immunoglobulin treatment in women with four or more recurrent spontaneous primary abortions of unexplained aetiology,” Human Reproduction, vol. 13, no. 9, pp. 2620–2623, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Dwyer, “Drug therapy: manipulating the immune system with immune globulin,” New England Journal of Medicine, vol. 326, no. 2, pp. 107–116, 1992. View at Google Scholar · View at Scopus
  13. M. D. Kazatchkine and S. V. Kaveri, “Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin,” New England Journal of Medicine, vol. 345, no. 10, pp. 747–755, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Mueller-Eckhardt, “Intravenous immunoglobulin in the prevention of recurrent miscarriage,” British Journal of Obstetrics and Gynaecology, vol. 101, no. 12, pp. 1072–1077, 1994. View at Google Scholar · View at Scopus
  15. O. B. Christiansen, O. Mathiesen, M. Husth et al., “Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin,” Human Reproduction, vol. 10, no. 10, pp. 2690–2695, 1995. View at Google Scholar · View at Scopus
  16. C. B. Coulam, L. Krysa, J. J. Stern, and M. Bustillo, “Intravenous immunoglobulin for treatment of recurrent pregnancy loss,” American Journal of Reproductive Immunology, vol. 34, no. 6, pp. 333–337, 1995. View at Google Scholar · View at Scopus
  17. A. Perino, A. Vassiliadis, A. Vucetich et al., “Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian study,” Human Reproduction, vol. 12, no. 11, pp. 2388–2392, 1997. View at Google Scholar · View at Scopus
  18. M. D. Stephenson, K. Dreher, E. Houlihan, and V. Wu, “Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial,” American Journal of Reproductive Immunology, vol. 39, no. 2, pp. 82–88, 1998. View at Google Scholar · View at Scopus
  19. B. Jablonowska, A. Selbing, M. Palfi, J. Ernerudh, S. Kjellberg, and B. Lindton, “Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study,” Human Reproduction, vol. 14, no. 3, pp. 838–841, 1999. View at Google Scholar · View at Scopus
  20. Practice Committee of the American Society for Reproductive Medicine, “Intravenous immunoglobulin (IVIG) and recurrent spontaneous pregnancy loss,” Fertility and Sterility, vol. 86, supplement 5, pp. S226–S227, 2006. View at Google Scholar
  21. B. Hutton, R. Sharma, D. Fergusson et al., “Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review,” British Journal of Obstetrics and Gynaecology, vol. 114, no. 2, pp. 134–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Morikawa, H. Yamada, E. H. Kato et al., “Massive intravenous immunoglobulin treatment in women with four or more recurrent spontaneous abortions of unexplained etiology: down-regulation of NK cell activity and subsets,” American Journal of Reproductive Immunology, vol. 46, no. 6, pp. 399–404, 2001. View at Google Scholar · View at Scopus
  23. L. O. Carreras, G. N. Perez, H. R. Vega, and F. Casavilla, “Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin,” The Lancet, vol. 2, no. 8607, pp. 393–394, 1988. View at Google Scholar · View at Scopus
  24. J. Y. H. Kwak, F. M. Y. Kwak, S. W. Ainbinder, A. M. Ruiz, and A. E. Beer, “Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions,” American Journal of Reproductive Immunology, vol. 35, no. 4, pp. 363–369, 1996. View at Google Scholar · View at Scopus
  25. J. E. Ruiz, J. Y. H. Kwak, L. Baum et al., “Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion,” American Journal of Reproductive Immunology, vol. 35, no. 4, pp. 370–375, 1996. View at Google Scholar · View at Scopus
  26. R. Perricone, G. Di Muzio, C. Perricone et al., “High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins,” American Journal of Reproductive Immunology, vol. 55, no. 3, pp. 232–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. A. Clark, K. Wong, D. Banwatt et al., “CD200-dependent and nonCD200-dependant pathways of NK cell suppression by human IVIG,” Journal of Assisted Reproduction and Genetics, vol. 25, no. 2-3, pp. 67–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Shimada, M. Takeda, J. Nishihira et al., “A high dose of intravenous immunoglobulin increases CD94 expression on natural killer cells in women with recurrent spontaneous abortion,” American Journal of Reproductive Immunology, vol. 62, no. 5, pp. 301–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. O. Graphou, A. Chioti, A. Pantazi et al., “Effect of intravenous immunoglobulin treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions,” American Journal of Reproductive Immunology, vol. 49, no. 1, pp. 21–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Yamada, M. Morikawa, I. Furuta et al., “Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood,” American Journal of Reproductive Immunology, vol. 49, no. 2, pp. 84–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Perricone, C. De Carolis, R. Giacomelli, M. D. Guarino, G. De Sanctis, and L. Fontana, “GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment,” American Journal of Reproductive Immunology, vol. 50, no. 3, pp. 232–237, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Takeda, H. Yamada, K. Iwabuchi et al., “Administration of high-dose intact immunoglobulin has an anti-resorption effect in a mouse model of reproductive failure,” Molecular Human Reproduction, vol. 13, no. 11, pp. 807–814, 2007. View at Publisher · View at Google Scholar · View at Scopus